| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.027 | 0.9 |